These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6129645)

  • 1. Failure of MIF-1 or naloxone to reverse ischemic-induced neurologic deficits in gerbils.
    Kastin AJ; Nissen C; Olson RD
    Pharmacol Biochem Behav; 1982 Nov; 17(5):1083-5. PubMed ID: 6129645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative effects of prolyl-leucyl-glycinamide and naloxone on morphine-induced inhibition of gastrointestinal transit.
    Pillai NP; Bhargava HN
    Pharmacol Biochem Behav; 1984 Sep; 21(3):365-8. PubMed ID: 6149566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of Tyr-MIF-1, MIF-1, and naloxone on peptide YY-induced hyperphagia.
    Hagan MM; Moss DE
    Peptides; 1994; 15(2):243-5. PubMed ID: 7911993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MIF-I's differential actions as an opiate antagonist.
    Kastin AJ; Olson RD; Ehrensing RH; Berzas MC; Schally AV; Coy DH
    Pharmacol Biochem Behav; 1979 Dec; 11(6):721-3. PubMed ID: 43981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MIF-I suppresses deprivation-induced fluid consumption in rats.
    Olson RD; Kastin AJ; Olson GA; King BM; Von Almen TK; Berzas MC; Ibanez ML; Coy DH
    Peptides; 1980; 1(4):353-7. PubMed ID: 6117840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low doses of naloxone and MIF-1 peptides increase fluid consumption in rats.
    Olson RD; Fernandez RC; Kastin AJ; Olson GA; Delatte SW; von Almen TK; Erickson DG; Hastings DC; Coy DH
    Pharmacol Biochem Behav; 1981 Dec; 15(6):921-4. PubMed ID: 6119705
    [No Abstract]   [Full Text] [Related]  

  • 7. Antagonistic actions of MIF-I on the hypothermia and hypomotility induced by beta-endorphin or morphine.
    Yehuda S; Kastin AJ; Coy DH
    Int J Neurosci; 1980; 11(4):317-20. PubMed ID: 6108937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of Tyr-MIF-1 and naloxone in two animal models involving benzodiazepine.
    Kastin AJ; Schwartzenburg D; Tsui L; Miller LG; Olson GA; Olson RD
    Brain Res Bull; 1989 Dec; 23(6):443-6. PubMed ID: 2575442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Existence of antiopiate systems as illustrated by MIF-1/Tyr-MIF-1.
    Galina ZH; Kastin AJ
    Life Sci; 1986 Dec; 39(23):2153-9. PubMed ID: 2878336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of MIF-I, sex, and weight on tonic immobility in lizards (Anolis carolinensis).
    Cashner FM; Delatte SW; von Almen TK; Olson GA; Olson RD
    Pharmacol Biochem Behav; 1982 Jun; 16(6):1017-9. PubMed ID: 6125952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tyr-MIF-1 acts as an opiate antagonist in the tail-flick test.
    Kastin AJ; Stephens E; Ehrensing RH; Fischman AJ
    Pharmacol Biochem Behav; 1984 Dec; 21(6):937-41. PubMed ID: 6151669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Picrotoxin-induced seizures modified by morphine and opiate antagonists.
    Thomas J; Nores WL; Kenigs V; Olson GA; Olson RD
    Pharmacol Biochem Behav; 1993 Jul; 45(3):615-7. PubMed ID: 8101378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tyr-MIF-1 attenuates antinociceptive responses induced by three models of stress-analgesia.
    Galina ZH; Kastin AJ
    Br J Pharmacol; 1987 Apr; 90(4):669-74. PubMed ID: 2884005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential inhibitory effects of MIF-1, Tyr-MIF-1, naloxone and beta-funaltrexamine on body rotation-induced analgesia in the meadow vole, Microtus pennsylvanicus.
    Lipa SM; Kavaliers M; Ossenkopp KP
    Peptides; 1989; 10(3):493-7. PubMed ID: 2571138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of neonatal treatment with Tyr-MIF-1 and naloxone on the long-term body weight gain induced by repeated postnatal stressful stimuli.
    d'Amore A; Loizzo A
    Peptides; 1999 Dec; 20(12):1425-30. PubMed ID: 10698117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naloxone-like actions of MIF-1 do not require the presence of the pituitary.
    Kastin AJ; Nissen C; Zadina JE; Schally AV; Ehrensing RH
    Pharmacol Biochem Behav; 1980 Dec; 13(6):907-12. PubMed ID: 6111087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrathecal Tyr-W-MIF-1 produces potent, naloxone-reversible analgesia modulated by alpha 2-adrenoceptors.
    Gergen KA; Zadina JE; Kastin AJ; Paul D
    Eur J Pharmacol; 1996 Mar; 298(3):235-9. PubMed ID: 8846821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Similar antagonism of morphine analgesia by MIF-1 and naloxone in Carassius auratus.
    Ehrensing RH; Michell GF; Kastin AJ
    Pharmacol Biochem Behav; 1982 Oct; 17(4):757-61. PubMed ID: 6129644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tyr-MIF-1 and hemorphin can act as opiate agonists as well as antagonists in the guinea pig ileum.
    Zadina JE; Kastin AJ; Kersh D; Wyatt A
    Life Sci; 1992; 51(11):869-85. PubMed ID: 1355851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analgesic effects of Tyr-W-MIF-1: a mixed mu2-opioid receptor agonist/mu1-opioid receptor antagonist.
    Gergen KA; Zadina JE; Paul D
    Eur J Pharmacol; 1996 Nov; 316(1):33-8. PubMed ID: 8982647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.